drugset / Trial / NCT02708394

Molecular Mechanisms of Antipsychotic-induced Insulin Resistance

NCT02708394

Phase 0 Completed 31 enrolled Wayne State University
RandomizedParallel-groupTriple-blindOther

Summary

This study will investigate the molecular mechanisms of atypical-antipsychotic induced insulin resistance. This will be accomplished by administering olanzapine or placebo to healthy subjects for 7 days and analyzing genetic and protein changes in peripheral tissues known to play an important role in insulin resistance pathophysiology.

Timeline

Start
2017-02-01
Primary completion
2023-10-01
Completion
2023-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule

Indications

No indication recorded.